Optical and visual quality of different refractive surgery procedures

Article

Assesing different procedures in the same eye with an adaptive optics visual simulator

In recent years, more patients want to correct their refractive error by means of refractive surgery. Although the most popular option to correct refractive error is laser in situ keratomileusis (LASIK), actually, other options, such as phakic intraocular lens (IOL) implantation, are growing.

The Visian Implantable Collamer lens (ICL, STAAR surgical, Nidau, Switzerland) is a posterior chamber phakic intraocular lens approved by the US FDA for the treatment of moderate to severe myopia. Implantation of this lens is a good alternative for patients with high levels of myopia or hyperopia or with thin corneas, which may not be good candidates for LASIK.1

The observer viewed the visual test generated on a microdisplay through the adaptiveoptics system and artificial pupil. So, it is possible to measure the visual acuity and contrast sensitivity achieved for different wavefront patterns. This technology allows us to determine the impact on the visual performance of different surgical techniques before the surgical procedure actually takes place in the same patient and under the same conditions.

The first study

The other aberrations that we evaluated (coma, trefoil, tetrafoil and secondary astigmatism) were minimal. Differences in spherical aberration and total higher order aberrations (HOAs) root mean square (RMS) values were found to be between lowmedium and high powers, but these differences were clinically negligible on visual quality after its implantation.

Besides, we have to take into account that these ICLs should be implanted, so the negative spherical aberration that has the ICLs could benefit many patients, because normally corneas have a positive spherical aberration.

In our research,3 to bear out the outcomes of the first study, we used the adaptive optics visual simulator to simulate different powers of ICLs (–3, –6 and –15 D) for small- and largeincision surgery from the ICLs' wavefront aberrations. Visual acuity and contrast sensitivity were measured in 11 observers for 3 and 5 mm pupils.

Regarding the effect of the incision surgery, we found significantly better outcomes for small-incision surgery, because the larger the incision size, the greater the HOAs that were induced. So, it should be preferable to implant a toric ICL through a small incision instead of a spherical ICL through a large incision.

As mentioned earlier, the ICL power affects the optical quality. In this study, we did not find differences between –3 and –6 D ICL, but they did become apparent for –15 D ICL. However, these losses are offset by the effect of spectacle magnification, which occurs when myopic patients undergo ICL implantation surgery. This can be attributed to the refractive correction of moving from the spectacle plane to the eye.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.